High Chiral Purity
Enzymatic cleavage is highly specific, enabling direct synthesis of chiral Glyceraldehyde e.g. D-Glyceraldehyde without costly chiral separation.
Glyceraldehyde is a versatile three-carbon sugar used extensively as a Chemical Intermediate in the synthesis of complex carbohydrates, pharmaceuticals, and chiral molecules. Its production faces significant challenges: High cost and instability of chemical synthesis; limited availability of food-grade product. This limits its use, particularly in high-purity or food-grade applications.
CD Biosynsis focuses on a highly pure, enzymatic route: Enzymatic Cleavage: Use Aldolase enzyme to cleave Fructose-1,6-bisphosphate (or other sugars) into Glyceraldehyde and Dihydroxyacetone Phosphate. This step offers high specificity and yield. Crucially, we utilize a Cell-free system for high purity. This eliminates cellular byproducts, ensuring the production of high-purity, food-grade Glyceraldehyde that is difficult to achieve with traditional chemical or whole-cell fermentation methods.
Get a QuoteGlyceraldehyde production is hindered by several chemical and stability issues:
A Cell-free enzymatic system provides the necessary specificity and purity.
CD Biosynsis utilizes an enzyme-based, cell-free biomanufacturing platform for Glyceraldehyde:
Aldolase Enzymatic Cleavage
We employ high-activity aldolase enzymes to cleave sugar intermediates e.g. Fructose-1,6-bisphosphate into Glyceraldehyde and DHAP, ensuring high selectivity.
Cell-free System for High Purity
We utilize purified enzymes in a cell-free environment to avoid cellular side reactions and byproducts, delivering high purity Glyceraldehyde.
In Situ Product Stabilization
We design the reaction conditions to stabilize Glyceraldehyde against dimerization and racemization, maintaining chiral integrity e.g. D-Glyceraldehyde.
Cofactor Regeneration and Cost Efficiency
If needed, we integrate highly efficient cofactor regeneration systems e.g. NADPH into the cell-free system to reduce operational costs.
This enzymatic approach guarantees high purity, chiral integrity, and sustainability for Glyceraldehyde production.
Our Glyceraldehyde engineering service offers these core benefits:
High Chiral Purity
Enzymatic cleavage is highly specific, enabling direct synthesis of chiral Glyceraldehyde e.g. D-Glyceraldehyde without costly chiral separation.
Food-Grade and Pharma-Grade Ready
The cell-free system produces a cleaner product, meeting strict regulatory standards for food and pharmaceutical use.
Avoids Toxic Byproducts
The mild enzymatic reaction replaces harsh chemical oxidizing agents, eliminating toxic byproducts and waste.
Cost-Efficient Enzyme Use
By using a cell-free system, enzymes can be immobilized or recycled efficiently, leading to lower operational costs.
Mild Reaction Conditions
The process operates at near-neutral pH and ambient temperatures, reducing energy consumption and preventing product degradation.
We deliver a sustainable, high-purity solution for Glyceraldehyde supply.
Our Glyceraldehyde engineering service follows a rigorous enzymatic workflow:
Technical communication is maintained throughout the process, focusing on timely feedback regarding yield and product stability attributes.
Explore the potential for a stable, high-purity Glyceraldehyde supply. CD Biosynsis provides customized strain and process engineering solutions:
Why is chiral purity important for Glyceraldehyde?
Glyceraldehyde has a single chiral center D-or L-form, making it a critical chiral building block for complex molecules. In pharmaceutical synthesis, only one enantiomer is often biologically active or safe. The enzymatic route naturally produces a single enantiomer e.g. D-Glyceraldehyde, avoiding the inefficiency of chiral resolution in chemical synthesis.
Why use a cell-free system instead of whole cells?
While whole cells are often easier to grow, a cell-free system offers superior control and purity. Whole cells contain many side pathways that degrade Glyceraldehyde. A cell-free system isolates only the necessary enzyme aldolase, preventing side reactions and eliminating cellular contaminants e.g. proteins and lipids from the final product.
What is Fructose-1,6-bisphosphate FBP and why is it the ideal substrate?
Fructose-1,6-bisphosphate FBP is a metabolic intermediate in glycolysis that is easily derived from low-cost sugars. FBP is the natural substrate of aldolase. Using it allows the enzyme to operate at peak efficiency and high selectivity, producing Glyceraldehyde and Dihydroxyacetone Phosphate DHAP with minimal side products.
What is the estimated project timeline?
A comprehensive project involving enzyme production, cell-free reaction optimization, and product stabilization protocols typically requires 25-35 weeks for final high-purity Glyceraldehyde protocol delivery and purity validation.
CRISPR-Cas9 technology represents a transformative advancement in gene editing techniques. The main function of the system is to precisely cut DNA sequences by combining guide RNA (gRNA) with the Cas9 protein. This technology became a mainstream genome editing tool quickly after its 2012 introduction because of its efficient, simple and low-cost nature.
The CRISPR gene editing system with its Cas9 version stands as a vital instrument for current biological research. CRISPR technology enables gene knockout (KO) through permanent gene expression blockage achieved by sequence disruption. Various scientific domains including disease modeling and drug screening employ this technology to study gene functions. CRISPR KO technology demonstrates high efficiency and precision but requires confirmation and verification post-implementation because unsatisfactory editing may produce off-target effects or incomplete gene knockouts which impact experimental result reliability. For precise and efficient Gene Editing Services - CD Biosynsis, Biosynsis offers comprehensive solutions tailored to your research needs.
The CRISPR-Cas9 knockout cell line was developed using CRISPR/Cas9 gene editing to allow scientists to remove genes accurately for research on gene function and disease models and pharmaceutical discovery. Genetic research considers this technology essential due to its high efficiency together with simple operation and broad usability.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
|
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.